Sign in
IPXL Stock Price, Chart, Stats & News
Impax Laboratories, Inc.
Save
Impax Laboratories, Inc. (IPXL) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
IPXL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 31.02% |
Operating margin | -51.91% |
Pretax margin | -58.13% |
Net margin | -60.49% |
Effective tax rate | -4.06% |
ROA | -34.73% |
ROE | -115.71% |
D/E | 4.21x |
Interest coverage ratio | -7.54x |
IPXL valuation
P/E | – |
P/S | – |
P/B | 7.02x |
P/CF | 17.63x |
P/FCF | – |
P/OCF | 17.63x |
PEG | -0.03x |
EV multiple | 2.31x |
About
Impax Laboratories, Inc. is a specialized pharmaceutical firm distinguished by its technological foundation. Its primary endeavors involve the research and development, production, and market introduction of precision drug delivery mechanisms, generic drug compositions, and proprietary branded medications. The company's activities are organized into two key operational units: Impax Generics and Impax Specialty Pharma.
Similar securities
Based on sector and market capitalization
Report issue